Skip to main content
logo
Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
5.40
-0.22 (-3.91%)
At close: Sep 9, 2026

SHA:688373 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
164.33141.77130.2790.7848.217.66
Revenue Growth
20.39%8.83%43.51%88.31%529.33%-
Gross Profit
141120.24107.8774.0839.386.9
Operating Income
-146.91-247.21-438.66-439.98-257.52-269.3
Net Income
-140.5-241.61-440.72-421.12-220.3-226.27
Earnings Per Share
-0.22-0.37-0.67-0.64-0.38-0.43
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
393.58451.64593.62953.31,270471.88
Total Debt
235.38379.62301.86221.19230.21160.99
Net Cash (Debt)
158.1972.02291.76732.111,040310.88
Net Cash Growth
-5.31%-75.32%-60.15%-29.60%234.52%-50.69%
Net Cash Per Share
0.250.110.441.121.790.59

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-115.87-210.18-447.18-329.08-240.01-180.98
Capital Expenditures
-0.38-0.55-0.91-7.66-12.18-22.91
Free Cash Flow
-116.25-210.73-448.1-336.74-252.18-203.89
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
85.80%84.81%82.80%81.61%81.70%90.08%
Operating Margin
-89.39%-174.37%-336.72%-484.69%-534.19%-3515.62%
Pretax Margin
-89.56%-173.21%-333.54%-457.34%-456.98%-2953.41%
Profit Margin
-85.50%-170.42%-338.31%-463.91%-456.99%-2953.91%
FCF Margin
-70.74%-148.64%-343.97%-370.96%-523.13%-2661.81%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.5627.9324.8547.13120.42-